Gilani Masood, Kaiser Daniel R, Bratteli Christopher W, Alinder Cheryl, Rajala Scott, Bank Alan J, Cohn Jay N
Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA; Current address: Bay Pines VA Hospital, St. Petersburg, Florida, USA.
J Am Soc Hypertens. 2007 Jan-Feb;1(1):45-55. doi: 10.1016/j.jash.2006.11.002.
Systemic inhibition of nitric oxide (NO) synthesis raises blood pressure, and endothelial dysfunction with reduced NO bioactivity is a precursor of atherosclerosis. Pre-hypertensive blood pressures place patients at increased risk for cardiovascular morbid events. Whether NO deficiency contributes to this increased risk has not been explored. Constitutive NO release was inhibited by infusion of the substituted arginine NG-nitro-L-arginine-methyl ester (L-NAME) in 10 normal volunteers. Hemodynamics, radial artery pulse contour analysis, brachial artery ultrasound, and aortic pulse wave velocity were monitored as well as plasma neurohormone levels. A modest rise in blood pressure within the normotensive range (113/65 to 124/77 mm Hg, P < .01) was accompanied by a rise in estimated systemic vascular resistance (1193 to 1514 dyne-sec-cm-5, P < .001). Pulse contour analysis revealed a fall to abnormal levels in systemic small artery elasticity (diastolic decay) (9.8 to 6.4 ml/mm Hg, P < .001) and a less consistent but significant increase in the second pressure peak in systole (P < .05). Large artery elasticity index, brachial artery caliber, and brachial artery compliance were unchanged. Flow-mediated brachial artery dilation was blunted slightly (5.29% to 4.47%, P = .06), and aortic pulse wave velocity increased slightly but significantly (8.25 to 8.98 m/s, P = .04), probably as a result of the rise in pressure. The magnitude of effect of L-NAME on small artery elasticity (-31.2% +/- 18.4%) was significantly greater and more consistent than its effect on other vascular measurements. Circulating neurohormonal vasoconstrictor levels fell or were unchanged after L-NAME, and a significant reduction in plasma norepinephrine was closely inversely correlated with the rise in blood pressure. Nitroglycerin infusion in 4 additional subjects produced selective relaxation in small arteries, whereas norepinephrine constricted both small and large arteries. A hemodynamic state consistent with pre-hypertension was induced by NO synthase inhibition in normal volunteers. Reduction in small artery compliance was a sensitive marker for this induced endothelial dysfunction and may serve as a useful marker for pre-hypertensive patients at risk for cardiovascular morbid events.
一氧化氮(NO)合成的全身性抑制会升高血压,而内皮功能障碍伴NO生物活性降低是动脉粥样硬化的先兆。高血压前期血压会使患者发生心血管疾病事件的风险增加。NO缺乏是否导致这种风险增加尚未得到研究。在10名正常志愿者中,通过输注替代精氨酸NG-硝基-L-精氨酸甲酯(L-NAME)来抑制内源性NO释放。监测血流动力学、桡动脉脉搏轮廓分析、肱动脉超声和主动脉脉搏波速度以及血浆神经激素水平。在正常血压范围内血压适度升高(从113/65至124/77 mmHg,P <.01),同时估计的全身血管阻力升高(从1193至1514达因-秒-厘米-5,P <.001)。脉搏轮廓分析显示全身小动脉弹性(舒张期衰减)降至异常水平(从9.8至6.4 ml/mmHg,P <.001),并且收缩期第二个压力峰值有不太一致但显著的增加(P <.05)。大动脉弹性指数、肱动脉内径和肱动脉顺应性未改变。血流介导的肱动脉扩张略有减弱(从5.29%至4.47%,P =.06),主动脉脉搏波速度略有但显著增加(从8.25至8.98 m/s,P =.04),这可能是压力升高的结果。L-NAME对小动脉弹性的影响程度(-31.2%±18.4%)比其对其他血管测量的影响显著更大且更一致。L-NAME后循环神经激素血管收缩剂水平下降或未改变,血浆去甲肾上腺素的显著降低与血压升高密切负相关。在另外4名受试者中输注硝酸甘油可使小动脉选择性舒张,而去甲肾上腺素则使小动脉和大动脉都收缩。正常志愿者中通过抑制NO合酶诱导出了与高血压前期一致的血流动力学状态。小动脉顺应性降低是这种诱导的内皮功能障碍的敏感标志物,并且可能作为有心血管疾病事件风险的高血压前期患者的有用标志物。